Which of the following chemotherapy agents is approved by FDA for use in radioiodine refractory papillary thyroid cancer :
a) Doxorubicin
b) Paclitaxel
c) Vincristine
d) Gemcitabine
Answers
Answered by
0
Question
Which of the following chemotherapy agents is approved by FDA for use in radioiodine refractory papillary thyroid cancer :
- Doxorubicin
- Paclitaxel
- Vincristine
- Gemcitabine
Answer
- DOXORUBICIN
Answered by
1
Answer:
Sorafenib is the first targeted systemic agent to demonstrate benefit in RAI-refractory thyroid cancer and was recently approved for the treatment of locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to RAI treatment [US Food and Drug Administration, 2013].
Similar questions